跳至主要内容
临床试验/ACTRN12611001133921
ACTRN12611001133921已完成不适用

The impact of human menopausal gonadotropin on follicular fluid hormone levels, embryo quality and IVF outcome in infertile women with mild male factor, unexplained and tubal factor infertility at ages between 25-35, undergoing controlled ovarian stimulation with recombinant FSH versus recombinant FSH+HMG

Gokce Anik Ilhan0 个研究点目标入组 70 人开始时间: 2011年10月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
25 Years 至 35 Years(—)
性别
Female

入选标准

  • mild male factor, tubal factor and unexplained infertility

排除标准

  • polycystic ovarian syndrome, poor responder patients (defined as having less than four follicles <15mm developed, or cycle cancellations in previous IVF attempts), previous fertilization failure (defined as fertilization rate less than 30% of the MII oocytes in a previous IVF cycle), any systemic, endocrine or metabolic illnesses, diminished ovarian reserve (defined as early follicular phase FSH>15 mIU/mL or AFC<5)

研究者

发起方
Gokce Anik Ilhan

相似试验